Embecta Corp.
NASDAQ:EMBCDrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $345.06M
- Beta
- 0.81
- P/E (TTM)
- 1.6
- EPS (TTM)
- $1.92
- Dividend yield
- 14.79%
Volume 0.72M
Average 1.95M
EMBC Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Embecta Corp.NASDAQ: EMBC
Selling, General & Admin · Q2 FY2026 · quarter ended Mar 2026
Selling, general & admin declines year over year
Q2 FY2026 selling, general & admin of $76.2M fell 3.8% year over year, ahead of the -5.1% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 1.8% from the prior quarter. Over 3 fiscal years it compounded at +4.0% a year.
Context
- Selling, general & admin amounted to 30.7% of revenue in FY2025, down 1.8 pp from a year earlier.
- Selling, general & admin increased in 2 of the last 3 fiscal years.
What to watch
Whether selling, general & admin reaches the consensus estimate from 3 analysts of $286.95M (-13.4%) for the fiscal year ending Sep 2026, a slowdown from the -9.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $76.2M-1.8% QoQ
- Last fiscal yearSep 2025
- $331.4M-9.2% YoY
- LTMMar 2026
- $325.1M-5.1% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 331.4M USD
- Year-over-year change
- -9.2%
- 4-year CAGR
- +8.4%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 331.4M | -9.2% |
| FY2024 | 2024-09-30 | 365.1M | +7.0% |
| FY2023 | 2023-09-30 | 341.3M | +15.8% |
| FY2022 | 2022-09-30 | 294.8M | +22.7% |
| FY2021 | 2021-09-30 | 240.3M | — |
Selling, General & Admin vs competitors
How EMBC compares with its peers on the latest reported figures
- EMBC's LTM Mar 2026 selling, general & admin of $325.1M is the 3rd highest of the 11 companies compared; the peer median is $166.62M.
- Its year-over-year change of -5.1% is the 9th highest of 10, against a peer median of +8.2%.
- Selling, general & admin amounts to 31.2% of revenue for EMBC, versus a peer median of 82.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $4.67T | +20374087.6% | -55.3% | 4982813.7% | |
| LTM Mar 2026 | $537.7M | -3.2% | +1.5% | 64.9% | |
| LTM Mar 2026 | $325.1M | -5.1% | +4.0% | 31.2% | |
| LTM Mar 2026 | $283.23M | +8.2% | +2.3% | 15.0% | |
| LTM Jun 2026 | $247.69M | +19.2% | +2.3% | 54.1% | |
| LTM Mar 2026 | $180.5M | -32.3% | -18.1% | 26.7% | |
| LTM Jun 2026 | $152.74M | -3.6% | +9.9% | 73.2% | |
| LTM Mar 2026 | $71.75M | +22.5% | +14.7% | 142.7% | |
| LTM Mar 2026 | $69.19M | — | — | 105.6% | |
| LTM Mar 2026 | $59.21M | +26.4% | -5.7% | 91.8% | |
| LTM Mar 2026 | $56.47M | +8.0% | +20.6% | 1399.8% | |
| Peer median (excluding EMBC) | $166.62M | +8.2% | +2.3% | 82.5% | |
Competitors are the stored peer set for EMBC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 1.17B | 1.13B | 1.12B | 1.12B | 1.08B |
| Cost of Revenue | 365M | 354.6M | 370.9M | 394.2M | 400.9M |
| Gross Profit | 800M | 774.9M | 749.9M | 728.9M | 679.5M |
| Gross Margin | 68.7% | 68.6% | 66.9% | 64.9% | 62.9% |
| Research & Development | 63M | 65M | 85.2M | 78.8M | 21.5M |
| Selling, General & Admin | 240.3M | 294.8M | 341.3M | 365.1M | 331.4M |
| Operating Expenses | 308M | 396.8M | 520.3M | 554.7M | 350.2M |
| Depreciation & Amortization | 38M | 31.7M | 32.7M | 42.5M | 51.1M |
| EBITDA | 533M | 334.5M | 245.4M | 199M | 294.7M |
| EBITDA Margin | 45.8% | 29.6% | 21.9% | 17.7% | 27.3% |
| Operating Income | 492M | 378.1M | 229.6M | 174.2M | 329.3M |
| Operating Margin | 42.2% | 33.5% | 20.5% | 15.5% | 30.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 46.2M | 107M | 112.3M | 107.3M |
| Other Income / Expenses | 3M | (121.5M) | (123.9M) | (130M) | (193M) |
| Income Before Tax | 495M | 256.6M | 105.7M | 44.2M | 136.3M |
| Pre-Tax Margin | 42.5% | 22.7% | 9.4% | 3.9% | 12.6% |
| Income Tax Expense | 80M | 33M | 35.3M | (34.1M) | 40.9M |
| Net Income | 414.8M | 223.6M | 70.4M | 78.3M | 95.4M |
| Net Margin | 35.6% | 19.8% | 6.3% | 7.0% | 8.8% |
| EPS (Basic) | 7.31 | 3.92 | 1.23 | 1.36 | 1.64 |
| EPS (Diluted) | 7.31 | 3.89 | 1.22 | 1.34 | 1.62 |
| Weighted Avg Shares | 56.8M | 57.06M | 57.24M | 58.43M | 58.31M |
| Weighted Avg Shares (Diluted) | 56.8M | 57.06M | 57.76M | 58.33M | 58.92M |
Embecta Corp.
NASDAQ:EMBC
Intrinsic Alpha fair value
Locked
Current Price
$6.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.